News
NXTS
1.880
+1.62%
0.030
Weekly Report: what happened at NXTS last week (0817-0821)?
Weekly Report · 2d ago
Weekly Report: what happened at NXTS last week (0810-0814)?
Weekly Report · 08/17 09:37
Weekly Report: what happened at NXTS last week (0803-0807)?
Weekly Report · 08/10 09:34
Weekly Report: what happened at NXTS last week (0727-0731)?
Weekly Report · 08/03 09:34
Nexentis Technologies Subsidiary MitoCareX Bio Narrows Its SLC Transport Protein Candidates To Select Candidate For A Drug Discovery Campaign
Benzinga · 07/28 12:13
Weekly Report: what happened at NXTS last week (0720-0724)?
Weekly Report · 07/27 09:36
Weekly Report: what happened at NXTS last week (0713-0717)?
Weekly Report · 07/20 09:35
Nexentis Technologies Files Prospectus For Offering 2.573M Common Shares On Behalf Of Selling Shareholders
Benzinga · 07/13 20:12
Nexentis Technologies registers to sell 2.57M shares of common stock for holders
TipRanks · 07/13 20:10
Weekly Report: what happened at NXTS last week (0706-0710)?
Weekly Report · 07/13 09:35
Nexentis Technologies Subsidiary Completes Analysis Of SLC Transport Proteins, Starts Global AI Drug Discovery Initiative With Boltz
Benzinga · 07/07 12:27
Weekly Report: what happened at NXTS last week (0629-0703)?
Weekly Report · 07/06 09:37
Nexentis Technologies announces monetization of Melz solar investment
TipRanks · 06/29 12:45
Nexentis Technologies Amends Its Loan And Partnership Agreement With Solterra Renewable Energy, Other Lenders For Melz Solar Project; Solterra To Make Early Partial Repayments Of ~$147K On Its Part Of Loan, $98K For Sale Of 10% Of Its Profit Rights;
Benzinga · 06/29 12:25
Weekly Report: what happened at NXTS last week (0622-0626)?
Weekly Report · 06/29 09:35
Crude Oil Down Over 1%; US Manufacturing PMI Surges In June
Benzinga · 06/23 16:02
3 Penny Stocks to Watch Today, 6/23/2026
TipRanks · 06/23 14:11
Nexentis Technologies Files Prospectus For Offering 410,998 Common Shares At $7.056/Share
Benzinga · 06/23 14:07
Dow Falls Over 300 Points; Korn Ferry Earnings Top Views
Benzinga · 06/23 13:49
Nexentis Technologies Soars 156% Before Falling 46% After Hours — Here’s Why NXTS Stock Is Trending
Benzinga · 06/23 05:48
More
Webull provides a variety of real-time NXTS stock news. You can receive the latest news about Nexentis Technologies Inc through multiple platforms. This information may help you make smarter investment decisions.
About NXTS
Nexentis Technologies Inc, formerly known as N2OFF, Inc., is an AI and data-driven computational biotech platform focused on mitochondrial biology, precision oncology and inflammatory metabolic diseases. Through its subsidiary MitoCareX Bio Ltd. The company uses a proprietary discovery engine targeting the mitochondrial SLC25 carrier family using its MITOLINE algorithm and structure guided virtual screening workflows. MITOLINE, its proprietary computational platform, is designed to allow proper homology modeling of mitochondrial membrane proteins, particularly transport proteins. It enables three-dimensional structural modeling and large-scale virtual screening, MITOLINE opens access to a novel untapped target space, allowing the Company to identify small-molecule modulators that directly disrupt cancer metabolism with the potential of minimizing systemic toxicity.